References
- Surgeons ASoAP. Cosmetic surgery national data bank 2010 statistics. 2010. Available from: http://www.surgery.org/sites/default/files/Stats2010_1.pdf [last accessed 16 Mar 2012]
- MacKenzie I, Burnstock G, Dolly JO. The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission. Neuroscience 1982;7:997–1006
- Monheit G. Neurotoxins: current concepts in cosmetic use on the face and neck–upper face (Glabella, forehead, and Crow's feet). Plastic Reconstruct Surg 2015;136:72s–5s
- Carruthers A, Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg 2001;20:71–84
- Jia Z, Lu H, Yang X, et al. Adverse events of botulinum toxin type A in facial rejuvenation: a systematic review and meta-analysis. Esthetic Plastic Surg 2016
- Pena MA, Alam M, Yoo SS. Complications with the use of botulinum toxin type A for cosmetic applications and hyperhidrosis. Semin Cutan Med Surg 2007;26:29–33
- Chen CS, Miller NR. Botulinum toxin injection causing lateral rectus palsy. Br J Ophthalmol 2007;91:843
- Sheen-Ophir S, Almog Y. [Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use]. Harefuah 2013;152:98–100